RESUMO
Recent studies suggest that killer cell immunoglobulin-like receptors (KIR) genotyping may be relevant to bone marrow/stem cell transplantation. The objective of this research was to develop a bead-based reverse sequence-specific oligonucleotide DNA hybridization assay for KIR genotyping using the Luminex platform. The oligonucleotide probes were designed to recognize 14 currently known KIR genes and two pseudogenes, as well as null alleles. A unique probe design was used to allow detection of two cis-polymorphic regions for typing of KIR2DS4, because the functioning alleles cannot readily be assigned by conventional probe detection systems. Assay performance was validated using DNA samples previously typed by the 13th International Histocompatibility Working Group with 100% concordant results.
Assuntos
DNA/genética , Sondas de Oligonucleotídeos , Receptores Imunológicos/genética , Alelos , Genótipo , Humanos , Células Matadoras Naturais/imunologia , Reação em Cadeia da Polimerase , Receptores Imunológicos/imunologia , Receptores KIRRESUMO
Monoclonal antibodies have played an important role in studying the biochemistry of the HLA-Class I molecules. Some murine anti-HLA mAbs can identify configurations of HLA epitopes that have never been reported in human allosera. One of these configurations is identified by an IgM mAb designated as: BHA-1441. This antibody was produced using a lymphoblastoid cell line typed as: A*02, A*25; B*38, B*4402/4405; C*0501, C*07, BW4, as the immunogen. A lymphocytotoxicity test of this mAb over a panel of 109 frozen, 452 fresh and, later, 44 DNA typed T cells revealed its specificity as B53, 37, 51, 52, +/- 44. All of the antigens recognized by this mAb share the Bw4 motif at positions 81-83, except for the HLA-B37, which shares only 82L and 83R. Furthermore, while B37 and B44 cross-react due to the aspartic acid (D) substitution at position 156, the reactivity with B53, B5 (51,52), B37 and 60% of B44 cells, makes it unlikely that the target epitope could be due only to the primary amino-acid sequence. The antibody-binding site might involve changes in tertiary structure and peptides bound by the MHC. BHA-1441 is an interesting tool to study and type the HLA-B53 antigen and its cross-reactive epitopes.
Assuntos
Anticorpos Monoclonais/metabolismo , Antígenos HLA/imunologia , Antígenos HLA-B/imunologia , Sequência de Aminoácidos , Animais , Reações Antígeno-Anticorpo , Linhagem Celular Transformada , Testes Imunológicos de Citotoxicidade , Feminino , Antígeno HLA-B37 , Antígeno HLA-B44 , Antígeno HLA-B51 , Antígeno HLA-B52 , Teste de Histocompatibilidade , Humanos , Hibridomas , Camundongos , Camundongos Endogâmicos BALB C , Dados de Sequência MolecularRESUMO
A flow cytometric method of simultaneously screening both HLA Class I and Class II panel reactive antibodies (PRA) was developed using a pool of 30 different Class I and 30 different Class II microbeads coated with purified HLA antigens. The antibodies in the serum that react specifically to the coated HLA antigens are detected by using a FITC-conjugated antibody against human IgG. Percent PRA can be determined by the percentage of microbeads that react positively to the serum. There is no cross-reactivity between the Class I and Class II microbeads. A mixture of Class I and Class II microbeads can be distinguished by their different fluorescent properties on the flow cytometry analysis. Thus, both Class I and Class II PRA can be detected from a single tube reaction.
